Cytotoxic CD4+ lymphocyte clones reactive with melanoma: The role of HLA and accessory molecules

P. S. Goedegebuure, L. W. Harel, L. G. Lemay, J. Kan-Mitchell, M. S. Mitchell

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

Tumor-infiltrating lymphocytes (TILs) were isolated from a patient with disseminated melanoma during active specific immunotherapy. Purified CD8+ TILs lysed autologous melanoma cells and one of three allogeneic melanoma cell lines. CD4+ TILs also lysed melanoma cell lines, but cytotoxicity was considerably lower than with CD8+ cultures. Neither the CD4+ nor the CD8+ culture lysed autologous EBV-transformed B cells in a 6- or 14-hr assay. These data were confirmed using CD4+ or CD8+ TIL clones. Coculture of autologous melanoma cells with rIFN-γ (100 U/ml) for 24 hr significantly enhanced cytolysis by CD4+ clones from 1.5-fold to more than 10-fold. This enhancement was associated in part with an increased cell surface expression of HLA class II molecules, because lysis by seven of nine CD4+ clones was almost completely blocked by anti-HLA class II MAb L227. Interestingly, both anti-HLA class I and anti-HLA class II MAbs blocked cytolysis by four of the nine CD4+ clones. Lysis by two CD4+ clones was blocked by anti-HLA class I MAb w6/32, but not by L227. The CD4 molecule was involved in the binding to HLA class II molecules or in signal transduction, since anti-CD4 MAb consistently inhibited cytotoxicity. Blocking of the known accessory molecule-ligand interactions CD11a,CD18 (LFA-1)-CD54 (ICAM-1 or -2) and CD2-CD58 (LFA-3) demonstrated the involvement of both interactions in the cytotoxicity by CD4+ clones. CD4+ CTLs may be important effector cells in vivo against melanomas expressing HLA class I and/or class II molecules.

Original languageEnglish
Pages (from-to)249-261
Number of pages13
JournalVaccine Research
Volume2
Issue number4
StatePublished - Dec 1 1993
Externally publishedYes

Fingerprint Dive into the research topics of 'Cytotoxic CD4<sup>+</sup> lymphocyte clones reactive with melanoma: The role of HLA and accessory molecules'. Together they form a unique fingerprint.

  • Cite this

    Goedegebuure, P. S., Harel, L. W., Lemay, L. G., Kan-Mitchell, J., & Mitchell, M. S. (1993). Cytotoxic CD4+ lymphocyte clones reactive with melanoma: The role of HLA and accessory molecules. Vaccine Research, 2(4), 249-261.